Stigma
Meeting category
Date(s)
10 Dec 2021
Program Language
English, Russian
Meeting type
Virtual Meeting
Organizer

Russian Stigma & Discrimination Forum 2021

Related Enduring Materials

Enduring Materials
Opening of the Program - 14:00
14:00 MSK
Opening Words
Mark Nelson, MA, MBBS, FRCP
Chelsea and Westminster Hospital / Imperial College Medical School, United Kingdom
Elena Orlova-Morozova, MD, PhD
Moscow Regional Center for the Prevention and Control of AIDS and Infectious Diseases, Russia
Session 1: Stigma and Discrimination in the Context of HIV - 14:10
14:10 MSK
Looking at Stigma Through the Eyes of an Epidemiologist
Evgenia Zhukova
Moscow Regional Center for the Prevention and Control of AIDS and Infectious Diseases, Russia
14:25 MSK
Stigma and Discrimination in the Context of People Who Inject Drugs
Peter Meylakhs, PhD
Higher School of Economics, Russia
14:40 MSK
Stigma and Discrimination Against Men Who Have Sex With Men
Dmitrii Tolkachev
Higher School of Economics, Russia
14:55 MSK
Panel Discussion
Evgenia Zhukova
Moscow Regional Center for the Prevention and Control of AIDS and Infectious Diseases, Russia
Peter Meylakhs, PhD
Higher School of Economics, Russia
Dmitrii Tolkachev
Higher School of Economics, Russia
Session 2: The Role of Successful Therapy: Non-detectable = Non-transferable - 15:35
15:35 MSK
Practical Aspects of N = N / U = U
Anton Eremin, MD
Moscow Regional Center for the Prevention and Control of AIDS and Infectious Diseases / AIDS.CENTER foundation, Russia
15:50 MSK
Overcome Implementation Challenges
Bruce Richman
Prevention Access Campaign, United States
16:05 MSK
The Importance of the U=U in Accepting the HIV-Positive Status
Leia Sekh
AIDS.CENTER foundation, Russia
16:20 MSK
Panel Discussion
Anton Eremin, MD
Moscow Regional Center for the Prevention and Control of AIDS and Infectious Diseases / AIDS.CENTER foundation, Russia
Bruce Richman
Prevention Access Campaign, United States
Leia Sekh
AIDS.CENTER foundation, Russia
End of the Program - 16:50
16:50 MSK
Closing Words
Mark Nelson, MA, MBBS, FRCP
Chelsea and Westminster Hospital / Imperial College Medical School, United Kingdom
Mekhty Alizadeh
Specialist in non-medical services for PLHIV, permanent expert of the Tolerance Center, Russia
Overview
Welcome

The Russian Stigma & Discrimination Forum 2021 took place virtually on 10 December 2021

As shown by the significant and increasing reports of cities and countries achieving the 90-90-90 targets and beyond for the majority, HIV is now a treatable infection. In the past few years, there have been advances not only in the efficacy of medication but as importantly, improvements in their toxicity profile and ease of administration, leading to greater adherence overall resulting in positive long-term results.

However, large groups of individuals either still remain undiagnosed, or are diagnosed but do not seek care. Indeed, undiagnosed individuals form the greatest gap in our 90-90-90 targets. For there to be further improvements in our cascades of care, it is essential that these groups are targeted.

But why does this happen?
Undoubtedly, this issue has much to do with fear. Particularly the fear of testing, receiving a positive diagnosis, attending an HIV center, and the subsequent discrimination which either does or is perceived to occur.
Such fears result in unnecessary morbidity and mortality, particularly due to late diagnosis, along with an increased risk of transmission within the population.

Change is coming!
We are, however, striving to make a change and there are success stories!
Come and hear how you can challenge and be part of the solution to stigma and discrimination. Listen to stories of both success and failure from our experienced faculty.
The triumph of HIV treatment can only truly begin when we can succeed in improving testing and linkage to care. We are all beholden to take part in this challenge.

Program Director
Local Chairs
Mehti, Alizade
Mekhty Alizadeh
Specialist in non-medical services for PLHIV, permanent expert of the Tolerance Center, Russia
General Information 
Unique Features
- Half-Day Forum
- Keynote Lectures
- Highly Interactive
- Panel Discussion
- Audience Discussion
Meeting Objectives
The objectives of this workshop are to:

- Highlight the issues of stigma and discrimination in different settings and from different perspectives;

- Summarize key strategies for the elimination of stigma and discrimination; and

- Strengthen the HIV care cascade in the Asian region, focusing on local solutions to fight stigma and discrimination.
Practical Information 
Certificate of Attendance
A digital certificate of attendance will be sent to participants after they successfully complete the forum program and post-meeting survey.
Language
The official language of the forum is Russian.
Disclaimer
This forum is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this forum, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this forum. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the forum.
Liability and Insurance
By registering for the forum participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Photographs, Audio, and Video Recording
Photographs, audio, and video recordings are not permitted at the official forum sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the forum is finished, provided the speaker has given permission to do so.
Support
Acknowledgment

"This educational activity is supported by an independent educational grant from ViiV Healthcare. ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity."

Endorsers